The U.S. Supreme Court is considering the liability of the OxyContin maker, Purdue Pharma, in the United States' opioid crisis. The High Court heard a challenge today from the Justice Department to a six-billion-dollar settlement that Purdue Pharma agreed to last year.
The settlement would have allowed members of the Sackler family, who controlled the company, to escape future litigation as a result of the pharmaceutical giant's role in the opioid epidemic, although they would have to forfeit $2 billion of their share of proceeds from a sale of the company.
However, the bankruptcy court decision. . .